The DPP family nonselective inhibitor Val-boroPro (talabostat) triggers a lytic form of programmed cell death known as pyroptosis in human acute myeloid leukemia (AML) cell lines and primary AML samples, an effect that is dependent on DPP9 inhibition [13]. The gene discussed is DPP9; the disease is acute myeloid leukemia.